Jaguar Health, Inc. Logo

Jaguar Health, Inc.

Develops plant-based prescription medicines for human and animal GI diseases.

JAGX | US

Overview

Corporate Details

ISIN(s):
US47010C6075
LEI:
Country:
United States of America
Address:
200 PINE STREET SUITE 400, 94104 SAN FRANCISCO

Description

Jaguar Health, Inc. is a commercial-stage pharmaceutical company that discovers, develops, and commercializes novel, proprietary, plant-based prescription medicines for both human and animal health. The company's primary focus is on addressing gastrointestinal (GI) diseases. Its core product, crofelemer, is a botanical drug sustainably derived from the Croton lechleri tree. For human health, crofelemer is in a Phase 3 clinical trial (OnTarget) for the preventative treatment of cancer therapy-related diarrhea and is also being studied for rare diseases like short bowel syndrome. In the animal health market, the company commercializes Canalevia-CA1, a prescription treatment for chemotherapy-induced diarrhea in dogs. Jaguar Health's pipeline spans multiple stages of development, leveraging its expertise in sustainably derived, plant-based therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Jaguar Health, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Jaguar Health, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Jaguar Health, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.